Literature DB >> 25696265

Stress echocardiography for risk assessment of diabetic patients.

L H B Baur, M Graal.   

Abstract

Coronary artery disease in patients suffering from diabetes mellitus will become an increasing problem in the future. Because diabetic patients benefit from treatment of symptomatic but also asymptomatic coronary artery disease, early diagnosis is warranted. The diagnostic techniques used to detect ischaemia, with a focus on stress echocardiography, are described.

Entities:  

Keywords:  coronary artery disease; diabetes mellitus; risk assessment; silent ischaemia; stress echocardiography

Year:  2004        PMID： 25696265      PMCID： PMC2497155     

Source DB:  PubMed          Journal:  Neth Heart J        ISSN： 1568-5888            Impact factor:   2.380


  15 in total

Review 1.  Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms.

Authors:  N B Schiller; P M Shah; M Crawford; A DeMaria; R Devereux; H Feigenbaum; H Gutgesell; N Reichek; D Sahn; I Schnittger
Journal:  J Am Soc Echocardiogr       Date:  1989 Sep-Oct       Impact factor: 5.251

2.  Clinical features of unrecognized myocardial infarction--silent and symptomatic. Eighteen year follow-up: the Framingham study.

Authors:  J R Margolis; W S Kannel; M Feinleib; T R Dawber; P M McNamara
Journal:  Am J Cardiol       Date:  1973-07       Impact factor: 2.778

3.  Exercise echocardiography or exercise SPECT imaging? A meta-analysis of diagnostic test performance.

Authors:  K E Fleischmann; M G Hunink; K M Kuntz; P S Douglas
Journal:  JAMA       Date:  1998-09-09       Impact factor: 56.272

4.  Usefulness of beta-blocker therapy in patients with non-insulin-dependent diabetes mellitus and coronary artery disease. Bezafibrate Infarction Prevention (BIP) Study Group.

Authors:  M Jonas; H Reicher-Reiss; V Boyko; A Shotan; L Mandelzweig; U Goldbourt; S Behar
Journal:  Am J Cardiol       Date:  1996-06-15       Impact factor: 2.778

5.  The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators.

Authors:  F M Sacks; M A Pfeffer; L A Moye; J L Rouleau; J D Rutherford; T G Cole; L Brown; J W Warnica; J M Arnold; C C Wun; B R Davis; E Braunwald
Journal:  N Engl J Med       Date:  1996-10-03       Impact factor: 91.245

6.  Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections.

Authors:  H King; R E Aubert; W H Herman
Journal:  Diabetes Care       Date:  1998-09       Impact factor: 19.112

7.  Safety and feasibility of dobutamine-atropine stress echocardiography for the diagnosis of coronary artery disease in diabetic patients unable to perform an exercise stress test.

Authors:  A Elhendy; R T van Domburg; D Poldermans; J J Bax; P R Nierop; M L Geleijnse; J R Roelandt
Journal:  Diabetes Care       Date:  1998-11       Impact factor: 19.112

8.  Significance of silent myocardial ischemia during exercise testing in patients with diabetes mellitus: a report from the Coronary Artery Surgery Study (CASS) Registry.

Authors:  D A Weiner; T J Ryan; L Parsons; L D Fisher; B R Chaitman; L T Sheffield; F E Tristani
Journal:  Am J Cardiol       Date:  1991-09-15       Impact factor: 2.778

9.  Atropine increases the accuracy of dobutamine stress echocardiography in patients taking beta-blockers.

Authors:  P M Fioretti; D Poldermans; A Salustri; T Forster; P Bellotti; E Boersma; A J McNeill; E S el-Said; J R Roelandt
Journal:  Eur Heart J       Date:  1994-03       Impact factor: 29.983

10.  Detection of coronary artery disease in diabetic patients.

Authors:  C Paillole; J Ruiz; J M Juliard; H Leblanc; R Gourgon; P Passa
Journal:  Diabetologia       Date:  1995-06       Impact factor: 10.122
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.